Regadenoson
NDC 43598-616, Regadenoson, injection, from Dr. Reddy's Laboratories Inc..
- Product NDC
- 43598-616
- Status
- Listed
- Labeler
- Dr. Reddy's Laboratories Inc.
- Dosage form
- INJECTION
- Route
- INTRAVENOUS
- Product type
- HUMAN PRESCRIPTION DRUG
- Marketing category
- ANDA
- Application
- ANDA213210
- DEA schedule
- None
curl https://api.healthcare.dev/v1/drugs/ndc/43598-616 \ -H "Authorization: Bearer $HDEV_API_KEY"
Product
Active ingredients and packages
Active ingredients
- REGADENOSON ANHYDROUS.08 mg/mL
Pharmacologic classes
Adenosine Receptor Agonists [MoA]; Pharmacologic Cardiac Stress Test Agent [EPC]
| Package NDC | NDC-11 | Package |
|---|---|---|
| 43598-616-11 | 43598061611 | 5 mL in 1 CARTON (43598-616-11) |
Linked data
RxNorm, label and prices
RxNorm concepts
RxNorm links no concept to this product's packages.
Related lookups
FDA label sections
GET /v1/drugs/labels/03ef6420-8190-a404-f7f6-def1864a77deMedicare Part B payment limits (ASP)
GET /v1/drugs/asp?ndc=43598-616
Use it
Look up 43598-616 from code or an agent
curl https://api.healthcare.dev/v1/drugs/ndc/43598-616 \ -H "Authorization: Bearer $HDEV_API_KEY"
Using the healthcare.dev MCP server, look up NDC 43598-616. Tell me the product, its labeler, dosage form and route, its packages, and the RxNorm concepts it maps to.
Source: FDA, release 2026-10-23. Public domain. Reference data, not medical advice.